Cardiology Practice Questions

Q: What are the potential causes of cardiogenic shock excluding myocardial infarction?

acute mitral regurgitation. ***acute mitral regurgitation*** - Severe acute mitral regurgitation can lead to **cardiogenic shock** by causing a sudden increase in left atrial pressure and pulmonary edema, reducing effective forward flow [1]. - This condition can result from **papillary muscle rupture** or dysfunction, often due to ischemia even in the absence of a large MI, or from infective endocarditis [1]. *ventricular septal rupture* - A ventricular septal rupture (VSR) is a mechanical complication of **myocardial infarction (MI)**, which is explicitly excluded in the question. - VSR creates a **left-to-right shunt**, leading to pulmonary overload and reduced systemic cardiac output, but it's fundamentally post-MI. *right heart failure* - While right heart failure can cause circulatory collapse, it is typically a component of **biventricular failure** or isolated in cases like severe pulmonary embolism [2]. - The question asks for causes of cardiogenic shock excluding MI, and pure **right heart failure** as a sole cause of global cardiogenic shock (affecting systemic perfusion) is less common without significant left heart involvement or severe pulmonary vascular disease. *All of the options* - This option is incorrect because **ventricular septal rupture** is almost exclusively a complication of myocardial infarction, which the question explicitly excludes. - Therefore, not all listed conditions are potential causes of cardiogenic shock *excluding MI*.

Q: In which of the following conditions is the implantation of an Automatic Implantable Cardioverter Defibrillator (AICD) indicated?

Ventricular tachycardia with structural heart disease. ***Ventricular tachycardia with structural heart disease*** - An **AICD** is strongly indicated for patients with **sustained ventricular tachycardia (VT)** in the presence of **structural heart disease** due to the high risk of sudden cardiac death [1]. - In these cases, the AICD can deliver **therapy (antitachycardia pacing or defibrillation)** to terminate life-threatening arrhythmias [1]. *Syncope due to arrhythmias* - While syncope due to arrhythmias can be serious, an **AICD** is not always the first or only treatment and its indication depends on the specific arrhythmia and underlying cause. - Other treatments like **ablation**, **antiarrhythmic medications**, or a **pacemaker** might be more appropriate depending on the type of arrhythmia (e.g., bradycardia). *None of the options* - This option is incorrect because **ventricular tachycardia with structural heart disease** is a clear and well-established indication for AICD implantation [1]. - AICDs are a cornerstone in the secondary prevention of sudden cardiac death in high-risk patients. *Brugada syndrome* - While **Brugada syndrome** carries a risk of sudden cardiac death, AICD implantation is typically reserved for patients who have experienced **symptomatic arrhythmias** (e.g., syncope, aborted sudden cardiac death) or have certain high-risk features, not for all asymptomatic cases. - Risk stratification in Brugada syndrome is complex, and an AICD is not universally indicated for every diagnosed individual.

Q: Roth spots are associated with which of the following conditions?

Acute leukaemia. **Acute leukaemia** - **Roth spots** are commonly observed in patients with **leukaemia**, characterized by **retinal hemorrhages** with pale centers due to leukemic cell infiltrates [1]. - The presence of these lesions is often an indicator of severe systemic disease [1]. *Bacterial endocarditis* - While **bacterial endocarditis** can cause various **ophthalmologic manifestations** like splinter hemorrhages and Janeway lesions, **Roth spots** are distinctly identified as hemorrhages with pale centers, which, though they can occur, are less characteristically associated than with leukaemia. - These hemorrhages in endocarditis are usually attributed to **immune complex deposition** or **septic emboli**. *Severe Hypertension* - **Severe hypertension** can lead to **hypertensive retinopathy**, presenting as **retinal hemorrhages**, cotton wool spots, and papilledema. - However, the classic description of **Roth spots** with their pale centers is not a direct or prominent feature of hypertensive retinopathy. *None of the options* - This option is incorrect because **Acute leukaemia** is clearly associated with **Roth spots**.

Q: Which drug is used as an adjunct to epinephrine in refractory ventricular fibrillation/ventricular tachycardia during cardiac arrest?

Amiodarone infusion. ***Amiodarone infusion*** - **Amiodarone** is a **Class III antiarrhythmic** drug commonly used in advanced cardiac life support (ACLS) protocols for refractory **ventricular fibrillation (VF)** or **pulseless ventricular tachycardia (VT)** that persists despite defibrillation and epinephrine [1]. - It works by blocking potassium channels, prolonging repolarization and the refractory period, which helps to stabilize the electrical activity of the heart. *Atropine* - **Atropine** is an anticholinergic drug primarily used to treat **symptomatic bradycardia** by increasing heart rate. - It is not indicated for the treatment of **ventricular fibrillation** or **ventricular tachycardia** during cardiac arrest. *High dose vasopressin* - **Vasopressin** was previously included in some ACLS algorithms as an alternative to epinephrine for **vasoconstrictive effects**, but recent guidelines do not support its routine use in cardiac arrest. - While it can cause **vasoconstriction**, there is no evidence that high-dose vasopressin improves outcomes in refractory VF/VT over epinephrine. *Adenosine* - **Adenosine** is an antiarrhythmic drug used to treat **supraventricular tachycardias (SVTs)** by transiently blocking the AV node. - It is not effective for **ventricular fibrillation** or **ventricular tachycardia** and can even be harmful in these rhythms.

Q: What does the CEAP score classify?

Chronic venous disorder. ***Chronic venous disorder*** - The **CEAP classification** is a standardized system for classifying **chronic venous disorders** [1]. - It stands for **Clinical, Etiological, Anatomical, and Pathophysiological**, providing a comprehensive description of the disease. *Atrial disorders* - **Atrial disorders** refer to conditions affecting the atria of the heart, such as atrial fibrillation, and are classified using different systems. - The CEAP score has **no relevance** to cardiac conditions. *Neurological disorders* - **Neurological disorders** pertain to conditions of the nervous system and are classified by systems tailored to their specific characteristics. - The CEAP score is **not applicable** to neurological diagnoses. *Traumatic disorders* - **Traumatic disorders** result from physical injury and are classified based on the nature and severity of the injury. - The CEAP score is **irrelevant** for assessing or classifying traumatic injuries.

Q: In a patient presenting with an ECG that shows ST-segment elevation but with a myocardial stunning pattern that does not correspond to a single coronary artery territory, what is the most likely diagnosis?

Takotsubo cardiomyopathy. **Takotsubo cardiomyopathy** - This condition is often triggered by **severe emotional or physical stress** and presents with acute chest pain, mimicking an MI, but with a distinctive pattern of **apical ballooning** or other regional wall motion abnormalities that do not correspond to a single coronary artery territory. - The ECG findings of **ST-segment elevation** associated with a myocardial stunning pattern that does not follow a specific coronary artery distribution are classic for Takotsubo cardiomyopathy, which is also known as **stress-induced cardiomyopathy**. *Restrictive cardiomyopathy* - This is characterized by **stiff, non-compliant ventricular walls** causing impaired diastolic filling, often leading to heart failure symptoms. - While it can cause abnormal ECG findings, it typically does not present with **acute ST-segment elevation** or a myocardial stunning pattern in a non-coronary distribution. *Brugada syndrome* - This is a **genetic channelopathy** associated with characteristic **ECG patterns (ST-segment elevation in V1-V3)** and an increased risk of ventricular arrhythmias and sudden cardiac death. - It is primarily an **electrical disorder** and does not involve myocardial stunning or wall motion abnormalities that mimic an acute myocardial infarction without corresponding coronary artery disease. *Pericarditis* - This condition involves **inflammation of the pericardium**, presenting with chest pain that often improves when leaning forward and widespread, **concave ST-segment elevation** on ECG. - While it causes ST-segment elevation, it does not typically show the specific **myocardial stunning pattern** or regional wall motion abnormalities that are characteristic of Takotsubo cardiomyopathy.

Q: Murmur heard in aortic stenosis

Right 2nd intercostal, high pitch systolic ejection murmur. ***Right 2nd intercostal, high pitch systolic ejection murmur*** - The murmur of **aortic stenosis** is classically heard loudest at the **right second intercostal space** (aortic area) due to turbulent flow through the stenosed aortic valve. - It is a **high-pitched, systolic ejection murmur** with a crescendo-decrescendo pattern, often radiating to the carotid arteries [2]. *Apex, low pitch murmur associated with mitral valve issues* - A murmur heard at the **apex** that is low-pitched typically suggests **mitral stenosis**, which is a diastolic rumble, not an aortic stenosis murmur [1]. - This option refers to characteristics associated with **mitral valve disease**, not aortic stenosis. *Pan-systolic murmur, high pitch murmur associated with mitral regurgitation* - A **pan-systolic murmur** is characteristic of conditions like **mitral regurgitation** or tricuspid regurgitation, where blood flows throughout the entire systole [3]. - While it can be high-pitched, its pan-systolic nature and association with mitral regurgitation make it distinct from aortic stenosis. *Left Sternal area, murmur indicating mitral regurgitation* - Murmurs heard primarily at the **left sternal area** can indicate various conditions, but this option specifically points to **mitral regurgitation**. - **Mitral regurgitation** is better heard at the apex and usually radiates to the axilla, and the description does not fit the typical presentation of aortic stenosis [3].

Q: The severity of mitral stenosis can be judged by-

Loud S1. ***Loud S1*** - A **loud S1** in mitral stenosis indicates that the **mitral valve leaflets are still mobile** and able to snap shut forcefully, which is characteristic of early to moderate stenosis [2]. - As mitral stenosis becomes more severe and the valve becomes calcified and rigid, the S1 sound may become diminished or even absent due to reduced leaflet mobility [1]. *Intensity of murmur* - The **intensity (loudness)** of the diastolic murmur in mitral stenosis **does not directly correlate with the severity** of the stenosis. - A loud murmur can be heard with mild stenosis, while a soft murmur in severe stenosis may be due to reduced cardiac output or left atrial pressure. *Duration of murmur* - While a **longer duration of the diastolic murmur** can coincide with more severe mitral stenosis, it is not as reliable a single indicator as other findings. - The duration is influenced by the pressure gradient across the valve and the length of diastole [2]. *Presence of left ventricular S3* - A **left ventricular S3** is typically associated with **left ventricular dysfunction** and volume overload, as seen in conditions like mitral regurgitation or dilated cardiomyopathy [3]. - It is **not a feature of mitral stenosis**, where the primary issue is obstruction to left ventricular filling.

Q: Which of the following is not recommended for patients with coronary artery disease?

Vitamin E. ***Vitamin E*** - **Vitamin E supplements** are generally not recommended for patients with coronary artery disease (CAD) based on current evidence. Some studies suggest a potential link between high doses of vitamin E and an increased risk of **heart failure** or even **overall mortality**. - There is no convincing evidence that vitamin E supplements provide cardiovascular benefits in patients with established CAD, and they may interfere with the efficacy of other beneficial medications like **statins**. *Daily exercise* - **Regular physical activity** is a cornerstone of CAD management, improving cardiovascular fitness, reducing blood pressure, and aiding in weight control [1]. - It helps in preventing disease progression and reducing the risk of future cardiovascular events when performed under appropriate medical guidance [1]. *Potassium* - Maintaining adequate **potassium levels** is crucial for patients with CAD, especially those on diuretics, as it helps regulate **blood pressure** and prevents **cardiac arrhythmias**. - Dietary sources of potassium (fruits, vegetables) are preferred, and supplementation may be necessary for those with deficiencies, but always under medical supervision. *Statins* - **Statins** are a class of medications widely recommended for patients with CAD due to their ability to significantly lower **LDL cholesterol** levels and reduce cardiovascular events [1]. - They stabilize **atherosclerotic plaques** and reduce inflammation, playing a critical role in secondary prevention of heart attacks and strokes [1].

Q: In the context of chest pain evaluation, which is the best way to differentiate between stable angina and NSTEMI?

Cardiac-biomarker. **Cardiac-biomarker** - **Cardiac biomarkers**, particularly **troponin**, are crucial for differentiating between **unstable angina** and **NSTEMI** [1], [2]. In NSTEMI, there is evidence of **myocardial necrosis**, leading to elevated cardiac troponins [2]. - **Stable angina** and **unstable angina** do not involve myocardial necrosis, so troponin levels remain within the normal range [1]. *ECG* - While an **ECG** is essential in the initial assessment of chest pain, it may show **non-specific changes** in both **unstable angina** and **NSTEMI**, such as T-wave inversions or ST-segment depression [2]. - The definitive distinction of **NSTEMI** often relies on **sequential biomarker measurements**, as ECG changes alone may not be sufficient for diagnosis or differentiation from unstable angina [2]. *Trans thoracic Echocardiography* - **Echocardiography** can show **regional wall motion abnormalities** that might suggest ischemia, but these findings are not specific enough to differentiate between **stable angina** and **NSTEMI** immediately. - It is more useful for assessing **ventricular function**, identifying **valvular disease**, or detecting other causes of chest pain, rather than acute differentiation of coronary syndromes. *Multi uptake gated Acquisition scan* - A **MUGA scan** assesses **left ventricular ejection fraction** and wall motion, primarily used in evaluating global cardiac function and monitoring cardiotoxicity from chemotherapy. - It is **not a first-line diagnostic tool** for differentiating between acute coronary syndromes like **stable angina** and **NSTEMI** because it does not directly detect acute myocardial injury.

Question 1

What are the potential causes of cardiogenic shock excluding myocardial infarction?

Accepted Answer

acute mitral regurgitation

Answer

All of the options

Answer

ventricular septal rupture

Answer

right heart failure

Question 2

In which of the following conditions is the implantation of an Automatic Implantable Cardioverter Defibrillator (AICD) indicated?

Accepted Answer

Ventricular tachycardia with structural heart disease

Answer

None of the options

Answer

Syncope due to arrhythmias

Answer

Brugada syndrome

Question 3

Roth spots are associated with which of the following conditions?

Accepted Answer

Acute leukaemia

Answer

Bacterial endocarditis

Answer

Severe Hypertension

Answer

None of the options

Question 4

Which drug is used as an adjunct to epinephrine in refractory ventricular fibrillation/ventricular tachycardia during cardiac arrest?

Accepted Answer

Amiodarone infusion

Answer

Atropine

Answer

Adenosine

Answer

High dose vasopressin

Question 5

What does the CEAP score classify?

Accepted Answer

Chronic venous disorder

Answer

Atrial disorders

Answer

Neurological disorders

Answer

Traumatic disorders

Question 6

In a patient presenting with an ECG that shows ST-segment elevation but with a myocardial stunning pattern that does not correspond to a single coronary artery territory, what is the most likely diagnosis?

Accepted Answer

Takotsubo cardiomyopathy

Answer

Restrictive cardiomyopathy

Answer

Brugada syndrome

Answer

Pericarditis

Question 7

Murmur heard in aortic stenosis

Accepted Answer

Right 2nd intercostal, high pitch systolic ejection murmur

Answer

Apex, low pitch murmur associated with mitral valve issues

Answer

Pan-systolic murmur, high pitch murmur associated with mitral regurgitation

Answer

Left Sternal area, murmur indicating mitral regurgitation

Question 8

The severity of mitral stenosis can be judged by-

Accepted Answer

Loud S1

Answer

Duration of murmur

Answer

Intensity of murmur

Answer

Presence of left ventricular S3

Question 9

Which of the following is not recommended for patients with coronary artery disease?

Accepted Answer

Vitamin E

Answer

Potassium

Answer

Statins

Answer

Daily exercise

Question 10

In the context of chest pain evaluation, which is the best way to differentiate between stable angina and NSTEMI?

Accepted Answer

Cardiac-biomarker

Answer

ECG

Answer

Trans thoracic Echocardiography

Answer

Multi uptake gated Acquisition scan

Cardiology — MCQs

Cardiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?